Abstract
PURPOSE American television viewers see as many as 16 hours of prescription drug advertisements (ads) each year, yet no research has examined how television ads attempt to influence consumers. This information is important, because ads may not meet their educational potential, possibly prompting consumers to request prescriptions that are clinically inappropriate or more expensive than equally effective alternatives.
METHODS We coded ads shown during evening news and prime time hours for factual claims they make about the target condition, how they attempt to appeal to consumers, and how they portray the medication and lifestyle behaviors in the lives of ad characters.
RESULTS Most ads (82%) made some factual claims and made rational arguments (86%) for product use, but few described condition causes (26%), risk factors (26%), or prevalence (25%). Emotional appeals were almost universal (95%). No ads mentioned lifestyle change as an alternative to products, though some (19%) portrayed it as an adjunct to medication. Some ads (18%) portrayed lifestyle changes as insufficient for controlling a condition. The ads often framed medication use in terms of losing (58%) and regaining control (85%) over some aspect of life and as engendering social approval (78%). Products were frequently (58%) portrayed as a medical breakthrough.
CONCLUSIONS Despite claims that ads serve an educational purpose, they provide limited information about the causes of a disease or who may be at risk; they show characters that have lost control over their social, emotional, or physical lives without the medication; and they minimize the value of health promotion through lifestyle changes. The ads have limited educational value and may oversell the benefits of drugs in ways that might conflict with promoting population health.
- Received for publication December 21, 2005.
- Revision received June 7, 2006.
- Accepted for publication June 26, 2006.
- © 2007 Annals of Family Medicine, Inc.
Jump to section
Related Articles
Cited By...
- US FDA breakthrough therapy designation and consumer drug advertising: a recipe for confusion
- Quality of advertisements for prescription drugs in family practice medical journals published in Australia, Canada and the USA with different regulatory controls: a cross-sectional study
- In This Issue: Sometimes More is Less
- An Updated Analysis of Direct-to-Consumer Television Advertisements for Prescription Drugs
- Ethical drug marketing criteria for the 21st century
- 'At-risk individuals responses to direct to consumer advertising of prescription drugs: a nationally representative cross-sectional study
- The Politics and Strategy of Industry Self-Regulation: The Pharmaceutical Industry's Principles for Ethical Direct-to-Consumer Advertising as a Deceptive Blocking Strategy
- Effects of Funding Policy Changes and Health Warnings on the Use of Erythropoiesis-Stimulating Agents
- Relationships with the drug industry: More regulation, greater transparency
- Le Canada devrait-il autoriser la publicite directe des medicaments d'ordonnance?: NON
- Should Canada allow direct-to-consumer advertising of prescription drugs?: NO
- Lack of Impact of Direct-to-Consumer Advertising on the Physician-Patient Encounter in Primary Care: A SNOCAP Report
- Direct to consumer advertising of prescription drugs
- On TRACK: Primary Care Opportunities for Filling Unmet Need
- On TRACK: Intended and Unintended Consequences of Direct-to-Consumer Drug Marketing
- Time to Ban Direct-to-Consumer Prescription Drug Marketing
- In This Issue: Doctor-Patient and Drug Company-Patient Communication
- Direct-to-Consumer Advertising: Is It Too Late to Manage the Risks?